J Virol. 1985 March; 53(3): 899-907
A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins.
S Crawford and
S P Goff
ABSTRACT
Deletion mutations in the 5' part of the pol gene of Moloney murine leukemia virus were generated by restriction enzyme site-directed mutagenesis of cloned proviral DNA. DNA sequence analysis indicated that one such deletion was localized entirely within the 5' part of the pol gene, did not affect the region encoding reverse transcriptase, and preserved the translational reading frame downstream of the mutation. The major viral precursor polyproteins (Pr65gag, Pr200gag-pol, and gPr80env) were synthesized at wild-type levels in cell lines carrying the mutant genome. These cell lines assembled and released wild-type levels of virion particles into the medium. Cleavage of both Pr65gag and Pr200gag-pol precursors to the mature proteins was completely blocked in the mutant virions. Surprisingly, these virions contained high levels of active reverse transcriptase; examination of the endogenous reverse transcription products synthesized by the mutant virions revealed normal amounts of minus-strand strong-stop DNA, indicating that the RNA genome was packaged and that reverse transcription in detergent-permeabilized virions was not significantly impaired. Processing of gPr80env to gP70env and P15E was not affected by the mutation, but cleavage of P15E to P12E was not observed. The mutant particles were poorly infectious; analysis indicated that infection was blocked at an early stage. The data are consistent with the idea that the 5' part of the pol gene encodes a protease directly responsible for processing Pr65gag, and possibly Pr200gag-pol, to the structural virion proteins. It appears that cleavage of the gag gene product is not required for budding and release of virions and that complete processing of the pol gene product to the mature form of reverse transcriptase is not required for its functional activation.
J Virol. 1985 March; 53(3): 899-907
This article has been cited by other articles:
-
Lin, Y.-C., Brik, A., de Parseval, A., Tam, K., Torbett, B. E., Wong, C.-H., Elder, J. H.
(2006). Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.. J. Virol.
80: 7832-7843
[Abstract]
[Full Text]
-
Feher, A., Boross, P., Sperka, T., Miklossy, G., Kadas, J., Bagossi, P., Oroszlan, S., Weber, I. T., Tozser, J.
(2006). Characterization of the murine leukemia virus protease and its comparison with the human immunodeficiency virus type 1 protease.. J. Gen. Virol.
87: 1321-1330
[Abstract]
[Full Text]
-
Cruceanu, M., Urbaneja, M. A., Hixson, C. V., Johnson, D. G., Datta, S. A., Fivash, M. J., Stephen, A. G., Fisher, R. J., Gorelick, R. J., Casas-Finet, J. R., Rein, A., Rouzina, I., Williams, M. C.
(2006). Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins. Nucleic Acids Res
34: 593-605
[Abstract]
[Full Text]
-
Roldan, A., Warren, O. U., Russell, R. S., Liang, C., Wainberg, M. A.
(2005). A HIV-1 Minimal Gag Protein Is Superior to Nucleocapsid at in Vitro Annealing and Exhibits Multimerization-induced Inhibition of Reverse Transcription. J. Biol. Chem.
280: 17488-17496
[Abstract]
[Full Text]
-
Baraz, L., Hutoran, M., Blumenzweig, I., Katzenellenbogen, M., Friedler, A., Gilon, C., Steinitz, M., Kotler, M.
(2002). Human immunodeficiency virus type 1 Vif binds the viral protease by interaction with its N-terminal region. J. Gen. Virol.
83: 2225-2230
[Abstract]
[Full Text]
-
Le Blanc, I., Prevost, M.-C., Dokhelar, M.-C., Rosenberg, A. R.
(2002). The PPPY Motif of Human T-Cell Leukemia Virus Type 1 Gag Protein Is Required Early in the Budding Process. J. Virol.
76: 10024-10029
[Abstract]
[Full Text]
-
Campbell, S., Oshima, M., Mirro, J., Nagashima, K., Rein, A.
(2002). Reversal by Dithiothreitol Treatment of the Block in Murine Leukemia Virus Maturation Induced by Disulfide Cross-Linking. J. Virol.
76: 10050-10055
[Abstract]
[Full Text]
-
Taylor, G. M., Gao, Y., Sanders, D. A.
(2001). Fv-4: Identification of the Defect in Env and the Mechanism of Resistance to Ecotropic Murine Leukemia Virus. J. Virol.
75: 11244-11248
[Abstract]
[Full Text]
-
Melikyan, G. B., Markosyan, R. M., Brener, S. A., Rozenberg, Y., Cohen, F. S.
(2000). Role of the Cytoplasmic Tail of Ecotropic Moloney Murine Leukemia Virus Env Protein in Fusion Pore Formation. J. Virol.
74: 447-455
[Abstract]
[Full Text]
-
Gorelick, R. J., Fu, W., Gagliardi, T. D., Bosche, W. J., Rein, A., Henderson, L. E., Arthur, L. O.
(1999). Characterization of the Block in Replication of Nucleocapsid Protein Zinc Finger Mutants from Moloney Murine Leukemia Virus. J. Virol.
73: 8185-8195
[Abstract]
[Full Text]
-
Taylor, G. M., Sanders, D. A.
(1999). The Role of the Membrane-spanning Domain Sequence in Glycoprotein-mediated Membrane Fusion. Mol. Biol. Cell
10: 2803-2815
[Abstract]
[Full Text]
-
Gao, G., Goff, S. P.
(1999). Somatic Cell Mutants Resistant to Retrovirus Replication: Intracellular Blocks during the Early Stages of Infection. Mol. Biol. Cell
10: 1705-1717
[Abstract]
[Full Text]
-
Feng, Y.-X., Campbell, S., Harvin, D., Ehresmann, B., Ehresmann, C., Rein, A.
(1999). The Human Immunodeficiency Virus Type 1 Gag Polyprotein Has Nucleic Acid Chaperone Activity: Possible Role in Dimerization of Genomic RNA and Placement of tRNA on the Primer Binding Site. J. Virol.
73: 4251-4256
[Abstract]
[Full Text]
-
Inabe, K., Nishizawa, M., Tajima, S., Ikuta, K., Aida, Y.
(1999). The YXXL Sequences of a Transmembrane Protein of Bovine Leukemia Virus Are Required for Viral Entry and Incorporation of Viral Envelope Protein into Virions. J. Virol.
73: 1293-1301
[Abstract]
[Full Text]
-
Kiernan, R. E., Freed, E. O.
(1998). Cleavage of the Murine Leukemia Virus Transmembrane Env Protein by Human Immunodeficiency Virus Type 1 Protease: Transdominant Inhibition by Matrix Mutations. J. Virol.
72: 9621-9627
[Abstract]
[Full Text]
-
Boden, D., Markowitz, M.
(1998). Resistance to Human Immunodeficiency Virus Type 1 Protease Inhibitors. Antimicrob. Agents Chemother.
42: 2775-2783
[Full Text]
-
Yu, Q., Ottmann, M., Pechoux, C., Le Grice, S., Darlix, J.-L.
(1998). Mutations in the Primer Grip of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Impair Proviral DNA Synthesis and Virion Maturation. J. Virol.
72: 7676-7680
[Abstract]
[Full Text]
-
Ohuchi, M., Fischer, C., Ohuchi, R., Herwig, A., Klenk, H.-D.
(1998). Elongation of the Cytoplasmic Tail Interferes with the Fusion Activity of Influenza Virus Hemagglutinin. J. Virol.
72: 3554-3559
[Abstract]
[Full Text]
-
Huang, Y., Khorchid, A., Gabor, J., Wang, J., Li, X., Darlix, J.-L., Wainberg, M. A., Kleiman, L.
(1998). The Role of Nucleocapsid and U5 Stem/A-Rich Loop Sequences in tRNA3Lys Genomic Placement and Initiation of Reverse Transcription in Human Immunodeficiency Virus Type 1. J. Virol.
72: 3907-3915
[Abstract]
[Full Text]
-
Ridky, T., Leis, J.
(1995). Development of Drug Resistance to HIV-1 Protease Inhibitors. J. Biol. Chem.
270: 29621-29623
[Full Text]
-
Erickson, J, Neidhart, D., VanDrie, J, Kempf, D., Wang, X., Norbeck, D., Plattner, J., Rittenhouse, J., Turon, M, Wideburg, N, et, al.
(1990). Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease. Science
249: 527-533
[Abstract]
-
Matayoshi, E., Wang, G., Krafft, G., Erickson, J
(1990). Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Science
247: 954-958
[Abstract]
-
Weber, I., Miller, M, Jaskolski, M, Leis, J, Skalka, A., Wlodawer, A
(1989). Molecular modeling of the HIV-1 protease and its substrate binding site. Science
243: 928-931
[Abstract]
Copyright © 1985 by the American Society for Microbiology. All rights reserved.